nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A5—Dactinomycin—skin cancer	0.161	0.227	CbGbCtD
Dopamine—CYP1A2—Imiquimod—skin cancer	0.128	0.181	CbGbCtD
Dopamine—CYP2C19—Vismodegib—skin cancer	0.0963	0.136	CbGbCtD
Dopamine—CYP2C9—Vismodegib—skin cancer	0.0801	0.113	CbGbCtD
Dopamine—CYP1A2—Vemurafenib—skin cancer	0.0703	0.0993	CbGbCtD
Dopamine—CYP2D6—Vemurafenib—skin cancer	0.0579	0.0818	CbGbCtD
Dopamine—CYP1A2—Dacarbazine—skin cancer	0.0538	0.0761	CbGbCtD
Dopamine—CYP1A2—Fluorouracil—skin cancer	0.0316	0.0446	CbGbCtD
Dopamine—CYP2C9—Fluorouracil—skin cancer	0.0284	0.0402	CbGbCtD
Dopamine—DRD5—eyelid—skin cancer	0.023	0.181	CbGeAlD
Dopamine—Azotaemia—Vismodegib—skin cancer	0.00848	0.184	CcSEcCtD
Dopamine—DBH—nerve—skin cancer	0.00797	0.0629	CbGeAlD
Dopamine—DRD1—nerve—skin cancer	0.00468	0.0369	CbGeAlD
Dopamine—SLC6A3—nerve—skin cancer	0.00376	0.0297	CbGeAlD
Dopamine—COMT—hair follicle—skin cancer	0.00353	0.0278	CbGeAlD
Dopamine—MAOB—nerve—skin cancer	0.00328	0.0259	CbGeAlD
Dopamine—SLC6A2—nerve—skin cancer	0.00304	0.0239	CbGeAlD
Dopamine—HTR7—nerve—skin cancer	0.00293	0.0231	CbGeAlD
Dopamine—MAOA—nerve—skin cancer	0.0028	0.0221	CbGeAlD
Dopamine—DRD2—nerve—skin cancer	0.00277	0.0218	CbGeAlD
Dopamine—HTR7—endothelium—skin cancer	0.00249	0.0197	CbGeAlD
Dopamine—COMT—nipple—skin cancer	0.00239	0.0189	CbGeAlD
Dopamine—HTR7—blood vessel—skin cancer	0.0023	0.0181	CbGeAlD
Dopamine—DBH—female reproductive system—skin cancer	0.00226	0.0179	CbGeAlD
Dopamine—Atrial fibrillation—Vemurafenib—skin cancer	0.00214	0.0464	CcSEcCtD
Dopamine—SLC22A3—nipple—skin cancer	0.00201	0.0159	CbGeAlD
Dopamine—Necrosis—Dactinomycin—skin cancer	0.00201	0.0436	CcSEcCtD
Dopamine—Extravasation—Bleomycin—skin cancer	0.00194	0.042	CcSEcCtD
Dopamine—Menorrhagia—Temozolomide—skin cancer	0.00193	0.0418	CcSEcCtD
Dopamine—DBH—head—skin cancer	0.00189	0.0149	CbGeAlD
Dopamine—MAOB—nipple—skin cancer	0.00186	0.0147	CbGeAlD
Dopamine—Atrial fibrillation—Imiquimod—skin cancer	0.00182	0.0395	CcSEcCtD
Dopamine—Extravasation—Dactinomycin—skin cancer	0.00181	0.0392	CcSEcCtD
Dopamine—DRD5—lymphoid tissue—skin cancer	0.0018	0.0142	CbGeAlD
Dopamine—DRD5—female reproductive system—skin cancer	0.00174	0.0137	CbGeAlD
Dopamine—Necrosis—Fluorouracil—skin cancer	0.00167	0.0363	CcSEcCtD
Dopamine—HTR7—neck—skin cancer	0.00164	0.013	CbGeAlD
Dopamine—MAOA—nipple—skin cancer	0.00159	0.0125	CbGeAlD
Dopamine—MAOA—neck—skin cancer	0.00157	0.0124	CbGeAlD
Dopamine—DRD3—head—skin cancer	0.00155	0.0122	CbGeAlD
Dopamine—COMT—skin of body—skin cancer	0.00153	0.0121	CbGeAlD
Dopamine—Extravasation—Fluorouracil—skin cancer	0.00151	0.0327	CcSEcCtD
Dopamine—SLC22A5—nipple—skin cancer	0.00146	0.0115	CbGeAlD
Dopamine—DRD5—head—skin cancer	0.00145	0.0115	CbGeAlD
Dopamine—ADRB1—connective tissue—skin cancer	0.00144	0.0113	CbGeAlD
Dopamine—SLC22A3—connective tissue—skin cancer	0.00143	0.0113	CbGeAlD
Dopamine—COMT—mammalian vulva—skin cancer	0.0014	0.011	CbGeAlD
Dopamine—CYP1A2—nipple—skin cancer	0.00132	0.0105	CbGeAlD
Dopamine—DBH—lymph node—skin cancer	0.00132	0.0104	CbGeAlD
Dopamine—MAOB—connective tissue—skin cancer	0.00132	0.0104	CbGeAlD
Dopamine—Necrosis—Docetaxel—skin cancer	0.00121	0.0262	CcSEcCtD
Dopamine—COMT—female reproductive system—skin cancer	0.0012	0.00944	CbGeAlD
Dopamine—HTR7—connective tissue—skin cancer	0.00118	0.00929	CbGeAlD
Dopamine—SLC22A3—mammalian vulva—skin cancer	0.00117	0.00927	CbGeAlD
Dopamine—MAOA—connective tissue—skin cancer	0.00113	0.00888	CbGeAlD
Dopamine—HTR7—epithelium—skin cancer	0.00112	0.00882	CbGeAlD
Dopamine—DRD1—head—skin cancer	0.00111	0.00876	CbGeAlD
Dopamine—Extravasation—Docetaxel—skin cancer	0.00109	0.0236	CcSEcCtD
Dopamine—MAOB—mammalian vulva—skin cancer	0.00109	0.00857	CbGeAlD
Dopamine—Vomiting—Vismodegib—skin cancer	0.00102	0.0222	CcSEcCtD
Dopamine—ADRB1—female reproductive system—skin cancer	0.00101	0.008	CbGeAlD
Dopamine—SLC22A3—female reproductive system—skin cancer	0.00101	0.00794	CbGeAlD
Dopamine—COMT—head—skin cancer	0.000999	0.00789	CbGeAlD
Dopamine—SLC6A4—female reproductive system—skin cancer	0.000979	0.00772	CbGeAlD
Dopamine—Nausea—Vismodegib—skin cancer	0.000957	0.0208	CcSEcCtD
Dopamine—SLC22A5—skin of body—skin cancer	0.000936	0.00739	CbGeAlD
Dopamine—MAOB—female reproductive system—skin cancer	0.000931	0.00734	CbGeAlD
Dopamine—MAOA—mammalian vulva—skin cancer	0.000927	0.00732	CbGeAlD
Dopamine—Palpitations—Imiquimod—skin cancer	0.000919	0.0199	CcSEcCtD
Dopamine—Hypertension—Imiquimod—skin cancer	0.000898	0.0195	CcSEcCtD
Dopamine—SLC6A3—head—skin cancer	0.000893	0.00704	CbGeAlD
Dopamine—Anxiety—Imiquimod—skin cancer	0.000883	0.0191	CcSEcCtD
Dopamine—SLC22A1—head—skin cancer	0.000879	0.00694	CbGeAlD
Dopamine—SLC6A2—female reproductive system—skin cancer	0.000862	0.0068	CbGeAlD
Dopamine—ADRB1—head—skin cancer	0.000847	0.00668	CbGeAlD
Dopamine—SLC22A3—head—skin cancer	0.00084	0.00663	CbGeAlD
Dopamine—HTR7—female reproductive system—skin cancer	0.000831	0.00655	CbGeAlD
Dopamine—Tachycardia—Imiquimod—skin cancer	0.000829	0.018	CcSEcCtD
Dopamine—SLC6A4—head—skin cancer	0.000818	0.00645	CbGeAlD
Dopamine—Angina pectoris—Fluorouracil—skin cancer	0.000803	0.0174	CcSEcCtD
Dopamine—MAOA—female reproductive system—skin cancer	0.000794	0.00627	CbGeAlD
Dopamine—MAOB—head—skin cancer	0.000778	0.00613	CbGeAlD
Dopamine—Dyspnoea—Imiquimod—skin cancer	0.000757	0.0164	CcSEcCtD
Dopamine—SLC22A5—female reproductive system—skin cancer	0.000731	0.00577	CbGeAlD
Dopamine—Atrial fibrillation—Docetaxel—skin cancer	0.000727	0.0158	CcSEcCtD
Dopamine—HTR1A—head—skin cancer	0.000726	0.00573	CbGeAlD
Dopamine—SLC6A2—head—skin cancer	0.00072	0.00568	CbGeAlD
Dopamine—COMT—lymph node—skin cancer	0.0007	0.00552	CbGeAlD
Dopamine—HTR7—head—skin cancer	0.000694	0.00548	CbGeAlD
Dopamine—MAOA—head—skin cancer	0.000663	0.00523	CbGeAlD
Dopamine—DRD2—head—skin cancer	0.000656	0.00518	CbGeAlD
Dopamine—Vomiting—Vemurafenib—skin cancer	0.000633	0.0137	CcSEcCtD
Dopamine—CYP2C9—female reproductive system—skin cancer	0.000629	0.00496	CbGeAlD
Dopamine—Headache—Vemurafenib—skin cancer	0.000624	0.0135	CcSEcCtD
Dopamine—Nausea—Vemurafenib—skin cancer	0.000591	0.0128	CcSEcCtD
Dopamine—SLC22A3—lymph node—skin cancer	0.000588	0.00464	CbGeAlD
Dopamine—Angina pectoris—Docetaxel—skin cancer	0.00058	0.0126	CcSEcCtD
Dopamine—Palpitations—Temozolomide—skin cancer	0.000551	0.0119	CcSEcCtD
Dopamine—MAOB—lymph node—skin cancer	0.000544	0.0043	CbGeAlD
Dopamine—Vomiting—Imiquimod—skin cancer	0.00054	0.0117	CcSEcCtD
Dopamine—Hypertension—Temozolomide—skin cancer	0.000538	0.0117	CcSEcCtD
Dopamine—Dyspnoea—Bleomycin—skin cancer	0.000538	0.0117	CcSEcCtD
Dopamine—Headache—Imiquimod—skin cancer	0.000532	0.0115	CcSEcCtD
Dopamine—Anxiety—Temozolomide—skin cancer	0.000529	0.0115	CcSEcCtD
Dopamine—Nausea—Imiquimod—skin cancer	0.000504	0.0109	CcSEcCtD
Dopamine—SLC6A2—lymph node—skin cancer	0.000504	0.00398	CbGeAlD
Dopamine—CYP2D6—female reproductive system—skin cancer	0.000472	0.00372	CbGeAlD
Dopamine—MAOA—lymph node—skin cancer	0.000465	0.00366	CbGeAlD
Dopamine—Tachycardia—Fluorouracil—skin cancer	0.000458	0.00992	CcSEcCtD
Dopamine—Dyspnoea—Temozolomide—skin cancer	0.000454	0.00984	CcSEcCtD
Dopamine—SLC22A5—lymph node—skin cancer	0.000428	0.00338	CbGeAlD
Dopamine—Dyspnoea—Fluorouracil—skin cancer	0.000418	0.00906	CcSEcCtD
Dopamine—CYP2D6—head—skin cancer	0.000394	0.00311	CbGeAlD
Dopamine—Vomiting—Bleomycin—skin cancer	0.000384	0.00832	CcSEcCtD
Dopamine—Palpitations—Docetaxel—skin cancer	0.000366	0.00795	CcSEcCtD
Dopamine—Nausea—Bleomycin—skin cancer	0.000358	0.00777	CcSEcCtD
Dopamine—Hypertension—Docetaxel—skin cancer	0.000358	0.00776	CcSEcCtD
Dopamine—Vomiting—Dactinomycin—skin cancer	0.000358	0.00776	CcSEcCtD
Dopamine—Nausea—Dactinomycin—skin cancer	0.000334	0.00725	CcSEcCtD
Dopamine—Tachycardia—Docetaxel—skin cancer	0.00033	0.00716	CcSEcCtD
Dopamine—Vomiting—Temozolomide—skin cancer	0.000324	0.00702	CcSEcCtD
Dopamine—Headache—Temozolomide—skin cancer	0.000319	0.00691	CcSEcCtD
Dopamine—Nausea—Temozolomide—skin cancer	0.000302	0.00655	CcSEcCtD
Dopamine—Dyspnoea—Docetaxel—skin cancer	0.000302	0.00654	CcSEcCtD
Dopamine—Vomiting—Fluorouracil—skin cancer	0.000298	0.00646	CcSEcCtD
Dopamine—Headache—Fluorouracil—skin cancer	0.000294	0.00637	CcSEcCtD
Dopamine—Nausea—Fluorouracil—skin cancer	0.000278	0.00604	CcSEcCtD
Dopamine—Vomiting—Docetaxel—skin cancer	0.000215	0.00467	CcSEcCtD
Dopamine—Headache—Docetaxel—skin cancer	0.000212	0.0046	CcSEcCtD
Dopamine—Nausea—Docetaxel—skin cancer	0.000201	0.00436	CcSEcCtD
Dopamine—SLC22A3—Metabolism—ENO2—skin cancer	7.07e-05	0.000591	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MC1R—skin cancer	7.06e-05	0.00059	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—GLI1—skin cancer	6.96e-05	0.000582	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—SMO—skin cancer	6.96e-05	0.000582	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PTCH1—skin cancer	6.96e-05	0.000582	CbGpPWpGaD
Dopamine—COMT—Neuronal System—HRAS—skin cancer	6.94e-05	0.00058	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PTCH1—skin cancer	6.86e-05	0.000574	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—SMO—skin cancer	6.86e-05	0.000574	CbGpPWpGaD
Dopamine—SLC6A4—Circadian rythm related genes—TP53—skin cancer	6.85e-05	0.000573	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PTGER4—skin cancer	6.77e-05	0.000566	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MC1R—skin cancer	6.76e-05	0.000565	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—PTGER4—skin cancer	6.7e-05	0.000561	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PTGER4—skin cancer	6.68e-05	0.000559	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GLI1—skin cancer	6.66e-05	0.000557	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—SHH—skin cancer	6.6e-05	0.000552	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SUFU—skin cancer	6.6e-05	0.000552	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CSPG4—skin cancer	6.53e-05	0.000546	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SHH—skin cancer	6.52e-05	0.000546	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—RASA1—skin cancer	6.48e-05	0.000542	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	6.44e-05	0.000539	CbGpPWpGaD
Dopamine—HTR7—Circadian rythm related genes—TP53—skin cancer	6.44e-05	0.000538	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—PTGER4—skin cancer	6.41e-05	0.000536	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GLI2—skin cancer	6.38e-05	0.000533	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTCH2—skin cancer	6.35e-05	0.000531	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SUFU—skin cancer	6.31e-05	0.000528	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—SHH—skin cancer	6.31e-05	0.000528	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GLI2—skin cancer	6.29e-05	0.000526	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—IL6—skin cancer	6.29e-05	0.000526	CbGpPWpGaD
Dopamine—SLC6A4—Circadian rythm related genes—IL6—skin cancer	6.27e-05	0.000524	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PTCH1—skin cancer	6.25e-05	0.000523	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—SMO—skin cancer	6.25e-05	0.000523	CbGpPWpGaD
Dopamine—DBH—Metabolism—PTGS2—skin cancer	6.22e-05	0.00052	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SMO—skin cancer	6.19e-05	0.000517	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PTCH1—skin cancer	6.19e-05	0.000517	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—TP53—skin cancer	6.16e-05	0.000515	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PTGER4—skin cancer	6.09e-05	0.000509	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MC1R—skin cancer	6.08e-05	0.000509	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CSPG4—skin cancer	6.08e-05	0.000509	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PTGER4—skin cancer	6.02e-05	0.000503	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MC1R—skin cancer	6e-05	0.000502	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GLI1—skin cancer	6e-05	0.000501	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PTCH1—skin cancer	5.98e-05	0.0005	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—SMO—skin cancer	5.98e-05	0.0005	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GLI1—skin cancer	5.92e-05	0.000495	CbGpPWpGaD
Dopamine—HTR7—Circadian rythm related genes—IL6—skin cancer	5.89e-05	0.000493	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PTGER4—skin cancer	5.82e-05	0.000487	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GLI2—skin cancer	5.73e-05	0.000479	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SUFU—skin cancer	5.68e-05	0.000475	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—IL6—skin cancer	5.64e-05	0.000472	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PTGER4—skin cancer	5.63e-05	0.000471	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SUFU—skin cancer	5.61e-05	0.000469	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—TP53—skin cancer	5.55e-05	0.000464	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—SHH—skin cancer	5.54e-05	0.000463	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GLI2—skin cancer	5.48e-05	0.000459	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—TP53—skin cancer	5.47e-05	0.000458	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MC1R—skin cancer	5.47e-05	0.000457	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GLI1—skin cancer	5.39e-05	0.000451	CbGpPWpGaD
Dopamine—MAOA—Transmission across Chemical Synapses—HRAS—skin cancer	5.39e-05	0.000451	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—IL6—skin cancer	5.35e-05	0.000447	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—FOXO4—skin cancer	5.32e-05	0.000445	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—SMO—skin cancer	5.25e-05	0.000439	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PTCH1—skin cancer	5.25e-05	0.000439	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ENO2—skin cancer	5.24e-05	0.000439	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MC1R—skin cancer	5.23e-05	0.000437	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GLI1—skin cancer	5.16e-05	0.000431	CbGpPWpGaD
Dopamine—COMT—Metabolism—ERCC2—skin cancer	5.12e-05	0.000428	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PTGER4—skin cancer	5.11e-05	0.000428	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SUFU—skin cancer	5.11e-05	0.000427	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—IL6—skin cancer	5.08e-05	0.000425	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SHH—skin cancer	5.03e-05	0.000421	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—IL6—skin cancer	5.01e-05	0.000419	CbGpPWpGaD
Dopamine—SLC6A3—Transmission across Chemical Synapses—HRAS—skin cancer	5.01e-05	0.000419	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—RASA1—skin cancer	5e-05	0.000418	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SUFU—skin cancer	4.89e-05	0.000409	CbGpPWpGaD
Dopamine—MAOB—Metabolism—ERCC2—skin cancer	4.86e-05	0.000406	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SHH—skin cancer	4.82e-05	0.000403	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GLI2—skin cancer	4.82e-05	0.000403	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—RASA1—skin cancer	4.79e-05	0.0004	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SMO—skin cancer	4.77e-05	0.000399	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PTCH1—skin cancer	4.77e-05	0.000399	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PTGER4—skin cancer	4.64e-05	0.000388	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MC1R—skin cancer	4.59e-05	0.000384	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SMO—skin cancer	4.57e-05	0.000382	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PTCH1—skin cancer	4.57e-05	0.000382	CbGpPWpGaD
Dopamine—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	4.56e-05	0.000381	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PLIN2—skin cancer	4.53e-05	0.000379	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GLI1—skin cancer	4.53e-05	0.000379	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PTGER4—skin cancer	4.44e-05	0.000372	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ENO2—skin cancer	4.44e-05	0.000371	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SHH—skin cancer	4.34e-05	0.000362	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RASA1—skin cancer	4.31e-05	0.00036	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SUFU—skin cancer	4.29e-05	0.000359	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SHH—skin cancer	4.28e-05	0.000358	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RASA1—skin cancer	4.25e-05	0.000355	CbGpPWpGaD
Dopamine—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	4.25e-05	0.000355	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—TP53—skin cancer	4.19e-05	0.00035	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PLIN2—skin cancer	4.17e-05	0.000348	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ENO2—skin cancer	4.13e-05	0.000346	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PLIN2—skin cancer	4.13e-05	0.000345	CbGpPWpGaD
Dopamine—MAOA—Neuronal System—HRAS—skin cancer	4.13e-05	0.000345	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTCH1—skin cancer	4.11e-05	0.000344	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SMO—skin cancer	4.11e-05	0.000344	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—ERCC2—skin cancer	4.11e-05	0.000343	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—FOXO4—skin cancer	4.1e-05	0.000343	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTCH1—skin cancer	4.05e-05	0.000339	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SMO—skin cancer	4.05e-05	0.000339	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTGER4—skin cancer	4e-05	0.000335	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTGER4—skin cancer	3.95e-05	0.00033	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—FOXO4—skin cancer	3.93e-05	0.000328	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SHH—skin cancer	3.9e-05	0.000326	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RASA1—skin cancer	3.87e-05	0.000324	CbGpPWpGaD
Dopamine—SLC6A3—Neuronal System—HRAS—skin cancer	3.84e-05	0.000321	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—IL6—skin cancer	3.83e-05	0.000321	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SHH—skin cancer	3.73e-05	0.000312	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RASA1—skin cancer	3.7e-05	0.00031	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SMO—skin cancer	3.69e-05	0.000309	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTCH1—skin cancer	3.69e-05	0.000309	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CSPG4—skin cancer	3.65e-05	0.000305	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTGER4—skin cancer	3.6e-05	0.000301	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TERT—skin cancer	3.55e-05	0.000297	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—FOXO4—skin cancer	3.53e-05	0.000295	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SMO—skin cancer	3.53e-05	0.000295	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTCH1—skin cancer	3.53e-05	0.000295	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PLIN2—skin cancer	3.53e-05	0.000295	CbGpPWpGaD
Dopamine—SLC22A2—Neuronal System—HRAS—skin cancer	3.49e-05	0.000292	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—FOXO4—skin cancer	3.49e-05	0.000292	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTGER4—skin cancer	3.44e-05	0.000288	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CSPG4—skin cancer	3.36e-05	0.000281	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CSPG4—skin cancer	3.33e-05	0.000278	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SHH—skin cancer	3.27e-05	0.000274	CbGpPWpGaD
Dopamine—SLC22A1—Neuronal System—HRAS—skin cancer	3.25e-05	0.000272	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RASA1—skin cancer	3.25e-05	0.000272	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—FOXO4—skin cancer	3.18e-05	0.000266	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTCH1—skin cancer	3.1e-05	0.000259	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SMO—skin cancer	3.1e-05	0.000259	CbGpPWpGaD
Dopamine—COMT—Metabolism—PTGS2—skin cancer	3.07e-05	0.000257	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ERCC2—skin cancer	3.05e-05	0.000255	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FOXO4—skin cancer	3.04e-05	0.000254	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTGER4—skin cancer	3.02e-05	0.000253	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—NRAS—skin cancer	2.99e-05	0.00025	CbGpPWpGaD
Dopamine—MAOB—Metabolism—PTGS2—skin cancer	2.91e-05	0.000243	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CSPG4—skin cancer	2.85e-05	0.000238	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—BRAF—skin cancer	2.81e-05	0.000235	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TERT—skin cancer	2.74e-05	0.000229	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FOXO4—skin cancer	2.67e-05	0.000223	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TERT—skin cancer	2.62e-05	0.000219	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ERCC2—skin cancer	2.58e-05	0.000215	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—KRAS—skin cancer	2.58e-05	0.000215	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ENO2—skin cancer	2.48e-05	0.000208	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PTGS2—skin cancer	2.46e-05	0.000206	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ERCC2—skin cancer	2.4e-05	0.000201	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TERT—skin cancer	2.36e-05	0.000197	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TERT—skin cancer	2.33e-05	0.000195	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—NRAS—skin cancer	2.31e-05	0.000193	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ENO2—skin cancer	2.28e-05	0.000191	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ENO2—skin cancer	2.26e-05	0.000189	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—NRAS—skin cancer	2.21e-05	0.000185	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—HRAS—skin cancer	2.19e-05	0.000183	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—BRAF—skin cancer	2.17e-05	0.000181	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TERT—skin cancer	2.12e-05	0.000177	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL6—skin cancer	2.1e-05	0.000175	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—BRAF—skin cancer	2.08e-05	0.000174	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TERT—skin cancer	2.03e-05	0.00017	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—NRAS—skin cancer	1.99e-05	0.000166	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—KRAS—skin cancer	1.99e-05	0.000166	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—NRAS—skin cancer	1.96e-05	0.000164	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.94e-05	0.000162	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ENO2—skin cancer	1.93e-05	0.000162	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—KRAS—skin cancer	1.9e-05	0.000159	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—BRAF—skin cancer	1.87e-05	0.000156	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—BRAF—skin cancer	1.84e-05	0.000154	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTGS2—skin cancer	1.83e-05	0.000153	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—NRAS—skin cancer	1.79e-05	0.000149	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TERT—skin cancer	1.78e-05	0.000149	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.77e-05	0.000148	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NRAS—skin cancer	1.77e-05	0.000148	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—KRAS—skin cancer	1.71e-05	0.000143	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—NRAS—skin cancer	1.71e-05	0.000143	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—KRAS—skin cancer	1.69e-05	0.000141	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—HRAS—skin cancer	1.69e-05	0.000141	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—BRAF—skin cancer	1.68e-05	0.000141	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—HRAS—skin cancer	1.62e-05	0.000135	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—skin cancer	1.62e-05	0.000135	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—BRAF—skin cancer	1.61e-05	0.000134	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—skin cancer	1.55e-05	0.000129	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—skin cancer	1.54e-05	0.000129	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—KRAS—skin cancer	1.54e-05	0.000129	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KRAS—skin cancer	1.52e-05	0.000127	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.51e-05	0.000126	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—NRAS—skin cancer	1.5e-05	0.000126	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—KRAS—skin cancer	1.47e-05	0.000123	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HRAS—skin cancer	1.45e-05	0.000122	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ERCC2—skin cancer	1.44e-05	0.000121	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—skin cancer	1.44e-05	0.00012	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HRAS—skin cancer	1.44e-05	0.00012	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BRAF—skin cancer	1.41e-05	0.000118	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—skin cancer	1.39e-05	0.000116	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—skin cancer	1.37e-05	0.000115	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NRAS—skin cancer	1.36e-05	0.000114	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—skin cancer	1.35e-05	0.000113	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ERCC2—skin cancer	1.33e-05	0.000111	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ERCC2—skin cancer	1.31e-05	0.00011	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—skin cancer	1.31e-05	0.000109	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NRAS—skin cancer	1.3e-05	0.000109	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—skin cancer	1.29e-05	0.000108	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KRAS—skin cancer	1.29e-05	0.000108	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—skin cancer	1.25e-05	0.000105	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—skin cancer	1.25e-05	0.000105	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—skin cancer	1.24e-05	0.000104	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—skin cancer	1.2e-05	0.0001	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NRAS—skin cancer	1.17e-05	9.82e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KRAS—skin cancer	1.17e-05	9.81e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NRAS—skin cancer	1.16e-05	9.69e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ERCC2—skin cancer	1.12e-05	9.39e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KRAS—skin cancer	1.12e-05	9.39e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—skin cancer	1.1e-05	9.18e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NRAS—skin cancer	1.06e-05	8.83e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—skin cancer	1.05e-05	8.79e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—skin cancer	1.04e-05	8.72e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KRAS—skin cancer	1.01e-05	8.45e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NRAS—skin cancer	1.01e-05	8.45e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—skin cancer	9.98e-06	8.35e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KRAS—skin cancer	9.98e-06	8.34e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—skin cancer	9.97e-06	8.34e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—skin cancer	9.55e-06	7.98e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—skin cancer	9.55e-06	7.98e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—skin cancer	9.14e-06	7.64e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KRAS—skin cancer	9.09e-06	7.6e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—skin cancer	8.99e-06	7.51e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NRAS—skin cancer	8.87e-06	7.42e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—skin cancer	8.87e-06	7.41e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KRAS—skin cancer	8.69e-06	7.27e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—skin cancer	8.65e-06	7.23e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—skin cancer	8.59e-06	7.19e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—skin cancer	8.48e-06	7.09e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—skin cancer	8.23e-06	6.88e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—skin cancer	8.12e-06	6.79e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—skin cancer	8.08e-06	6.76e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—skin cancer	7.95e-06	6.65e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—skin cancer	7.88e-06	6.59e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—skin cancer	7.73e-06	6.46e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—skin cancer	7.73e-06	6.46e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KRAS—skin cancer	7.63e-06	6.38e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—skin cancer	7.4e-06	6.18e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—skin cancer	7.39e-06	6.18e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—skin cancer	7.07e-06	5.91e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—skin cancer	6.79e-06	5.67e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—skin cancer	6.74e-06	5.63e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—skin cancer	6.49e-06	5.43e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—skin cancer	6.21e-06	5.19e-05	CbGpPWpGaD
